{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T19:10:34Z","timestamp":1649877034811},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1988,6,1]],"date-time":"1988-06-01T00:00:00Z","timestamp":581126400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[1988,6]]},"DOI":"10.1007\/bf02083709","type":"journal-article","created":{"date-parts":[[2005,8,15]],"date-time":"2005-08-15T01:37:33Z","timestamp":1124069853000},"page":"109-115","source":"Crossref","is-referenced-by-count":7,"title":["Cardiovascular drugs in children: Angiotensin-converting enzyme inhibitors"],"prefix":"10.1007","volume":"9","author":[{"given":"Adam","family":"Schneeweiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02083709_CR1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0031-3955(16)33535-0","volume":"25","author":"RD Adelman","year":"1978","unstructured":"Adelman RD (1978) Neonatal hypertension.Pediatr Clin North Am 25:99","journal-title":"Pediatr Clin North Am"},{"key":"BF02083709_CR2","first-page":"145","volume":"100","author":"H Bifano","year":"1982","unstructured":"Bifano H, et al. (1982) Treatment of neonatal hypertension with captopril.J Pediatr 100:145","journal-title":"J Pediatr"},{"key":"BF02083709_CR3","first-page":"6","volume":"78","author":"J Bing","year":"1970","unstructured":"Bing J, Poulsen K (1970) Effect of anti-angiotensin II on blood pressure and sensitivity to angiotensin and renin.Acta Pathol Microbiol Scand [A] 78:6","journal-title":"Acta Pathol Microbiol Scand [A]"},{"key":"BF02083709_CR4","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/clpt.1981.92","volume":"29","author":"J Biollaz","year":"1981","unstructured":"Biollaz J, Burnier M, Turini GA, et al. (1981) Three new long-acting converting-enzyme activity and response to angiotensin I.Clin Pharmacol Ther 29:665","journal-title":"Clin Pharmacol Ther"},{"key":"BF02083709_CR5","unstructured":"Boucek MM, et al. (1984) Elevated plasma renin in lambs with ventricular septal defect and hemodynamic improvement following captopril. American Heart Association"},{"key":"BF02083709_CR6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2125.1981.tb01151.x","volume":"11","author":"DB Brunner","year":"1981","unstructured":"Brunner DB, Desponds G, Biollaz J, et al. (1981) Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysin analogue on the components of the renin system in healthy subjects.Br J Clin Pharmacol 11:461","journal-title":"Br J Clin Pharmacol"},{"key":"BF02083709_CR7","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1126\/science.174.4016.1344","volume":"174","author":"HR Brunner","year":"1971","unstructured":"Brunner HR, Kirshman JD, Sealy JE, et al. (1971) Hypertension of renal origin: evidence for two different mechanisms.Science 174:1344","journal-title":"Science"},{"key":"BF02083709_CR8","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0140-6736(73)92657-3","volume":"2","author":"HR Brunner","year":"1973","unstructured":"Brunner HR, Cavras H, Laragh JHM, et al. (1973) Angiotensin II blockade in man by Sar1-ala8-angiotensin II for understanding and treatment of high blood pressure.Lancet 2:1045","journal-title":"Lancet"},{"key":"BF02083709_CR9","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1097\/00005344-198507001-00002","volume":"7","author":"HR Brunner","year":"1985","unstructured":"Brunner HR, Nussberger J, Waeber B (1985) The present molecules of converting enzyme inhibitors.J Cardiovasc Pharmacol 7:2S","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"BF02083709_CR10","first-page":"II","volume":"59","author":"DB Case","year":"1979","unstructured":"Case DB, et al. (1979) Successful acute and chronic treatment of severe and malignant hypertension with oral converting enzyme inhibitor captopril. [Abstr].Circulation [Suppl 2]59 and60:II-130","journal-title":"Circulation"},{"key":"BF02083709_CR11","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/0002-9149(82)90358-7","volume":"49","author":"DB Case","year":"1982","unstructured":"Case DB, et al. (1982) Long-term efficacy of captopril in renovascular and essential hypertension.Am J Cardiol 49:1440","journal-title":"Am J Cardiol"},{"key":"BF02083709_CR12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/clc.4960051009","volume":"5","author":"A Casta","year":"1982","unstructured":"Casta A, et al. (1982) Effective use of captopril in postoperative paradoxical hypertension of coarctation of the aorta.Clin Cardiol 5:551","journal-title":"Clin Cardiol"},{"key":"BF02083709_CR13","first-page":"453","volume":"55","author":"RJ Cody","year":"1978","unstructured":"Cody RJ, et al. (1978) Hemodynamics of orally active converting enzyme inhibitors (SQ 14225) in hypertensive patients.Clin Sci Mol Med 55:453","journal-title":"Clin Sci Mol Med"},{"key":"BF02083709_CR14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0140-6736(73)90468-6","volume":"1","author":"JG Collier","year":"1973","unstructured":"Collier JG, Robinson BF, Vanc JR (1973) Reduction of pressor effects of angiotensin I in man by synthetic nonapeptide (B.P.P.9a or SQ 20881) which inhibits converting enzyme.Lancet 1:72","journal-title":"Lancet"},{"key":"BF02083709_CR15","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/clpt.1982.59","volume":"31","author":"KL Duchin","year":"1982","unstructured":"Duchin KL, et al. (1982) Captopril kinetics.Clin Pharmacol Ther 31:452","journal-title":"Clin Pharmacol Ther"},{"key":"BF02083709_CR16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/00365517009049193","volume":"25","author":"I Eide","year":"1970","unstructured":"Eide I, Aars H (1970) Renal hypertension in rabbits immunized with angiotensin II.Scand J Clin Lab Invest 25:119","journal-title":"Scand J Clin Lab Invest"},{"key":"BF02083709_CR17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1161\/01.CIR.65.1.33","volume":"65","author":"R Fagard","year":"1982","unstructured":"Fagard R, et al. (1982) Response of the systemic and pulmonary circulation to converting-enzyme inhibition (captopril) at rest and during exercise in hypertensive patients.Circulation 65:33","journal-title":"Circulation"},{"key":"BF02083709_CR18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1476-5381.1965.tb02091.x","volume":"24","author":"SH Ferreira","year":"1965","unstructured":"Ferreira SH (1965) A bradykinin-potentiating factor (BPE) present in the venom ofBothrops jararaca.Br J Pharmacol Chemother 24:163","journal-title":"Br J Pharmacol Chemother"},{"key":"BF02083709_CR19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/01.CIR.61.1.163","volume":"61","author":"FM Fouad","year":"1980","unstructured":"Fouad FM, et al. (1980) Contrasts and similarities of acute hemodynamic responses to specific antagonism of angiotensin II (Sar, Thr, A II) and to inhibition of converting enzyme (captopril).Circulation 61:163","journal-title":"Circulation"},{"key":"BF02083709_CR20","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0022-3476(80)80038-2","volume":"97","author":"A Friedman","year":"1980","unstructured":"Friedman A, et al. (1980) Effective use of captopril (angiotensin I-converting enzyme inhibitor) in severe childhood hypertension.J Pediatr 97:664","journal-title":"J Pediatr"},{"key":"BF02083709_CR21","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJM197805042981803","volume":"298","author":"H Gavras","year":"1978","unstructured":"Gavras H, et al. (1978) Antihypertensive effect of oral angiotensin converting-enzyme inhibitor SQ 14225 in man.N Engl J Med 298:991","journal-title":"N Engl J Med"},{"key":"BF02083709_CR22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archinte.1984.00350130107020","volume":"144","author":"E Grossman","year":"1984","unstructured":"Grossman E, et al. (1984) Clinical use of captopril in Takayasu's disease.Arch Intern Med 144:95","journal-title":"Arch Intern Med"},{"key":"BF02083709_CR23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00007611-198103000-00028","volume":"74","author":"DV Hamilton","year":"1981","unstructured":"Hamilton DV, Maidment G (1981) Captopril for refractory hypertension in patients with chronic renal failure and renal transplanatation.JR Soc Med 74:357","journal-title":"JR Soc Med"},{"key":"BF02083709_CR24","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1476-5381.1968.tb08491.x","volume":"34","author":"PR Hedwall","year":"1968","unstructured":"Hedwall PR (1968) Effect of rabbit antibodies against angiotensin II on the pressor response to angiotensin II and renal hypertension in the rat.Br J Pharmacol Chemother 34:623","journal-title":"Br J Pharmacol Chemother"},{"key":"BF02083709_CR25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/pgmj.57.664.115","volume":"57","author":"JD Horowitz","year":"1981","unstructured":"Horowitz JD, et al. (1981) Effects of captopril (SQ 14225) in a patient with primary pulmonary hypertension.Postgrad Med J 57:115","journal-title":"Postgrad Med J"},{"key":"BF02083709_CR26","unstructured":"Ita CE, et al. (1987) Distribution of captopril to fetuses and milk of rats.Xenobiotica (in press)"},{"key":"BF02083709_CR27","first-page":"107","volume":"20","author":"S Kimoto","year":"1979","unstructured":"Kimoto S (1979) The history and present status of aortic surgery in Japan, particularly for aortitis syndrome.J Cardiovasc Surg 20:107","journal-title":"J Cardiovasc Surg"},{"key":"BF02083709_CR28","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/clpt.1980.90","volume":"27","author":"KJ Kripalani","year":"1980","unstructured":"Kripalani KJ, et al. (1980) Disposition of captopril in normal subjects.Clin Pharmacol Ther 27:636","journal-title":"Clin Pharmacol Ther"},{"key":"BF02083709_CR29","doi-asserted-by":"crossref","first-page":"193S","DOI":"10.1111\/j.1365-2125.1982.tb02077.x","volume":"14","author":"G Leibau","year":"1982","unstructured":"Leibau G, et al. (1982) Captopril in congestive heart failure.Br J Clin Pharmacol 14:193S","journal-title":"Br J Clin Pharmacol"},{"key":"BF02083709_CR30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/01.CIR.67.1.155","volume":"67","author":"CV Leier","year":"1983","unstructured":"Leier CV, et al. (1983) Captopril in primary pulmonary hypertension.Circulation 67:155","journal-title":"Circulation"},{"key":"BF02083709_CR31","unstructured":"Macda T, et al. (1979) Studies on the metabolism of a new antihypertensive agent, SQ 14225 (captopril). I. In vitro studies on the binding to plasma protein and behavior in blood. In:Proceedings of the 99th annual meeting of the Pharmaceutical Society of Japan, Sapporo, August 28\u201330."},{"key":"BF02083709_CR32","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0002-8703(83)90286-7","volume":"106","author":"S Mookerjee","year":"1983","unstructured":"Mookerjee S, et al. (1983) Acute effects of captopril on cardiopulmonary function, hemodynamics and renin-angiotensin-aldosterone-bradykinin profile in hypertension.Am Heart J 106:106","journal-title":"Am Heart J"},{"key":"BF02083709_CR33","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0022-3476(79)80787-8","volume":"95","author":"SE Oberfield","year":"1979","unstructured":"Oberfield SE, et al. (1979) Use of the oral angiotensin I-converting enzyme inhibitor (captopril) in childhood malignant hypertension.J Pediatr 95:641","journal-title":"J Pediatr"},{"key":"BF02083709_CR34","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3928\/0090-4481-19820701-11","volume":"11","author":"SE Oberfield","year":"1982","unstructured":"Oberfield SE, Rapaport R, Levine LS, New MI (1982) Captopril.Pediatr Ann 11:614","journal-title":"Pediatr Ann"},{"key":"BF02083709_CR35","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1021\/bi00798a004","volume":"10","author":"MA Ondetti","year":"1971","unstructured":"Ondetti MA, Williams NJ, Sabo EF, Pluscec J, Cleaver ER, Kocy O (1971) Angiotensin-converting enzyme inhibitors from the venom ofBothrops jararaca: isolation, elucidation of structure and synthesis.Biochemistry 10:4033","journal-title":"Biochemistry"},{"key":"BF02083709_CR36","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1126\/science.191908","volume":"196","author":"MA Ondetti","year":"1977","unstructured":"Ondetti MA, Rubin B, Cushman DW (1977) Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents.Science 196:441","journal-title":"Science"},{"key":"BF02083709_CR37","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/288280a0","volume":"288","author":"AA Patchett","year":"1980","unstructured":"Patchett AA, Harris E, Tristram EW, et al. (1980) A new class of angiotensin-converting enzyme inhibitors.Nature 288:280","journal-title":"Nature"},{"key":"BF02083709_CR38","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0022-3476(76)80811-6","volume":"89","author":"LB Plumer","year":"1976","unstructured":"Plumer LB, Kaplan GW, Mendoza SA (1976) Hypertension in infants: a complication of umbilical arterial catheterization.J Pediatr 89:802","journal-title":"J Pediatr"},{"key":"BF02083709_CR39","doi-asserted-by":"crossref","first-page":"16S","DOI":"10.1097\/00005344-198507001-00004","volume":"7","author":"AJ Reyes","year":"1985","unstructured":"Reyes AJ, Leary WP, Acosta-Barrios TN (1985) Once-daily administration of captopril and hypotensive effect.J Cardiovasc Pharmacol 7:16S","journal-title":"J Cardiovasc Pharmacol"},{"key":"BF02083709_CR40","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/hrt.48.3.272","volume":"48","author":"S Rich","year":"1982","unstructured":"Rich S, et al. (1982) Captopril as treatment for patients with pulmonary hypertension.Br Heart J 48:272","journal-title":"Br Heart J"},{"key":"BF02083709_CR41","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2165\/00003495-198325010-00002","volume":"25","author":"JA Romankiewicz","year":"1983","unstructured":"Romankiewicz JA, et al. (1983) Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure.Drugs 25:6","journal-title":"Drugs"},{"key":"BF02083709_CR42","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0022-3476(83)80490-9","volume":"103","author":"AR Sinaiko","year":"1983","unstructured":"Sinaiko AR, et al. (1983) Antihypertensive effect and elimination kinetics of captopril in hypertensive children with renal disease.J Pediatr 103:799","journal-title":"J Pediatr"},{"key":"BF02083709_CR43","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/j.1552-4604.1982.tb02661.x","volume":"22","author":"SM Singhvi","year":"1982","unstructured":"Singhvi SM, et al. (1982) Effect of food on the bioavailability of captopril in healthy subjects.J Clin Pharmacol 22:135","journal-title":"J Clin Pharmacol"},{"key":"BF02083709_CR44","doi-asserted-by":"crossref","first-page":"97S","DOI":"10.1111\/j.1365-2125.1982.tb02064.x","volume":"14","author":"Veterans Administration Co-operative Study Group on Antihypertensive Agents","year":"1982","unstructured":"Veterans Administration Co-operative Study Group on Antihypertensive Agents (1982) Racial differences in response to low-dose captopril are abolished by the addition of hydrochlorothiazide.Br J Clin Pharmacol 14:97S","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"BF02083709_CR45","first-page":"443S","volume":"63","author":"Veterans Administration Co-operative Study Group on Antihypertensive Agents","year":"1982","unstructured":"Veterans Administration Co-operative Study Group on Antihypertensive Agents (1982) Captopril in hypertension. [Suppl 8]63:443S","journal-title":"Captopril in hypertension"},{"key":"BF02083709_CR46","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/01.CIR.17.4.653","volume":"17","author":"GE Wakerlin","year":"1958","unstructured":"Wakerlin GE (1958) Antibodies to renin as proof of the pathogenesis of sustained renal hypertension.Circulation 17:653","journal-title":"Circulation"},{"key":"BF02083709_CR47","first-page":"326","volume":"20","author":"RA Weiser","year":"1969","unstructured":"Weiser RA, Johnson AG, Hoobler SW (1969) The effect of antirenin on the blood pressure of the rat with experimental renal hypertension.Lab Invest 20:326","journal-title":"Lab Invest"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02083709.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02083709\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02083709","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:26:46Z","timestamp":1557793606000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02083709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,6]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1988,6]]}},"alternative-id":["BF02083709"],"URL":"https:\/\/doi.org\/10.1007\/bf02083709","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,6]]}}}